NNVC Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for NanoViricides, Inc (NNVC.A) is -3.14, compared to its 5-year average forward P/E of -2.72. For a more detailed relative valuation and DCF analysis to assess NanoViricides, Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-2.72

Current PE

-3.14

Overvalued PE

-1.29

Undervalued PE

-4.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-4.18

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

8.09

Undervalued EV/EBITDA

-16.44

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.51

Current PS

0.00

Overvalued PS

1.98

Undervalued PS

-0.96

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

NNVC News & Events

Events Timeline

No data

News

9.5

2025-05-15Yahoo Finance

NanoViricides: Fiscal Q3 Earnings Snapshot

9.0

2025-03-07Business Insider

Biotech Alert: Searches spiking for these stocks today

4.0

2024-08-25SeekingAlpha

Earnings week ahead: NVIDIA, CrowdStrike, Salesforce, Lululemon and more (NASDAQ:NVDA)

People Also Watch

Frequently Asked Questions

What is NanoViricides, Inc (NNVC) stock price today?

The current price of NNVC is 1.12 USD — it has decreased -7.44 % in the last trading day.

What is NanoViricides, Inc (NNVC)'s business?

NanoViricides, Inc. is a clinical-stage company. The Company is engaged in developing a class of drugs that it calls nanoviricides, using a platform technology based on the application of nanomedicine technologies to the complex issues of viral diseases. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that has demonstrated activity in lethal lung infection animal model studies of Coronavirus (COVID), Respiratory Syncytial Virus, Influenza, Orthopoxvirus model for Smallpox and MPox, and even in a humanized mice model for Measles. It is focused on advancing Phase II clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles rash. Its NV-CoV-2 and NV-CoV-2-R are drug candidates for the treatment of COVID. Its portfolio also includes NV-HIV-1, a novel mechanism Anti-HIV Drug Candidate. Its other drug candidates include treatment for viral infections, including Dengue viruses, Ebola viruses, among others.

What is the price predicton of NNVC Stock?

Wall Street analysts forecast NNVC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NNVC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NanoViricides, Inc (NNVC)'s revenue for the last quarter?

NanoViricides, Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is NanoViricides, Inc (NNVC)'s earnings per share (EPS) for the last quarter?

NanoViricides, Inc. EPS for the last quarter amounts to -0.10 USD, decreased -56.52 % YoY.

What changes have occurred in the market's expectations for NanoViricides, Inc (NNVC)'s fundamentals?

The market is revising No Change the revenue expectations for NNVC for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -21.40%.

How many employees does NanoViricides, Inc (NNVC). have?

NanoViricides, Inc (NNVC) has 7 emplpoyees as of January 10 2026.

What is NanoViricides, Inc (NNVC) market cap?

Today NNVC has the market capitalization of 24.16M USD.